Vimarsana
Biggest News Aggregation in the World

Cogent Systems News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cogent Systems. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cogent Systems Today - Breaking & Trending Today

Where have all the IPOs gone? - Vimarsana News

Where have all the IPOs gone?

Since July 2022, 33 companies planning IPOs worth a combined ₹49,300 crore are said to have allowed their regulatory approvals to lapse

Zion Market Research: GLOBAL HEALTHCARE BIOMETRICS MARKET SIZE WORTH 12.35 BILLION BY 2028 - Vimarsana News

Zion Market Research: GLOBAL HEALTHCARE BIOMETRICS MARKET SIZE WORTH 12.35 BILLION BY 2028

NEW YORK, Feb. 10, 2022 /PRNewswire/ -- As per study of Zion Market Research, Healthcare Biometrics industry garnered revenue worth nearly US$ 3.95 billion in 2021 and is anticipated to gain

Biometric Technology Market Recorded Hyper Growth in the Future - Vimarsana News

Biometric Technology Market Recorded Hyper Growth in the Future

Biometric Technology Market Recorded Hyper Growth in the Future – 2030

Biometric Technology Market Recorded Hyper Growth in the Future - Vimarsana News

Biometric Technology Market Recorded Hyper Growth in the Future

Biometric Technology Market Recorded Hyper Growth in the Future – 2030

Fulgent Genetics' CEO Just Told Investors To Look Out For An Acquisition - Vimarsana News

Fulgent Genetics' CEO Just Told Investors To Look Out For An Acquisition

Apr 20, 2021 at 7:21AM The conference calls that follow a company's earnings report are rarely eventful. Usually, a few executives make a statement summarizing the performance of the business and then analysts ask questions. Occasionally, a comment will give shareholders insight into what the leadership team is really thinking. Fulgent Genetics' (NASDAQ:FLGT) CEO Ming Hsieh made one of these on the company's fourth quarter call in March. He mentioned the potential for an acquisition to expand the company's diagnostic and screening capabilities. Further, he specifically...

Source: fool.com